NEW YORK, March 8 - Leslie Misrock, a 73 year-old partner at Pennie & Edmonds in New York who has been called the father of Biotechnology Patent Law, is concerned about proteomics. With decades of biotechnology litigation under his belt, Misrock has warned industry leaders that battles over protein patents could stop proteomics dead in its tracks. This week, Genomeweb caught up with Misrock to discuss this issue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.